2013. Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer. Journal of Analytical Oncology. 2, 3 (Aug. 2013),  151–159. DOI:https://doi.org/10.6000/1927-7229.2013.02.03.4.